Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.
Talasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jimenez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van Tassell BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B. Talasaz AH, et al. Among authors: aghakouchakzadeh m. Nat Rev Cardiol. 2024 Mar 20. doi: 10.1038/s41569-024-01003-3. Online ahead of print. Nat Rev Cardiol. 2024. PMID: 38509244 Review.
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Talasaz AH, Sadeghipour P, Bakhshandeh H, Sharif-Kashani B, Rashidi F, Beigmohammadi MT, Moghadam KG, Rezaian S, Dabbagh A, Sezavar SH, Farrokhpour M, Abedini A, Aliannejad R, Riahi T, Yadollahzadeh M, Lookzadeh S, Rezaeifar P, Matin S, Tahamtan O, Mohammadi K, Zoghi E, Rahmani H, Hosseini SH, Mousavian SM, Abri H, Sadeghipour P, Baghizadeh E, Rafiee F, Jamalkhani S, Amin A, Mohebbi B, Parhizgar SE, Soleimanzadeh M, Aghakouchakzadeh M, Eslami V, Payandemehr P, Khalili H, Talakoob H, Tojari T, Shafaghi S, Tabrizi S, Kakavand H, Kashefizadeh A, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Ansarin K, Maleki M, Sadeghian S, Barco S, Siegerink B, Spatz ES, Piazza G, Kirtane AJ, Tassell BWV, Lip GYH, Klok FA, Goldhaber SZ, Stone GW, Krumholz HM, Bikdeli B. Talasaz AH, et al. Among authors: aghakouchakzadeh m. Thromb Haemost. 2023 Jul;123(7):723-733. doi: 10.1055/a-2059-4844. Epub 2023 Mar 21. Thromb Haemost. 2023. PMID: 36944357 Clinical Trial.
Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI).
Kakavand H, Saadatagah S, Naderian M, Aghakouchakzadeh M, Jalali A, Sadri F, Amoli AI, Hosseini SH, Jenab Y, Pourhosseini H, Salarifar M, Talasaz AH. Kakavand H, et al. Among authors: aghakouchakzadeh m. Naunyn Schmiedebergs Arch Pharmacol. 2023 Mar;396(3):557-565. doi: 10.1007/s00210-022-02368-3. Epub 2023 Mar 1. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36856810 Free PMC article. Clinical Trial.
A stepwise approach to prescribing novel lipid-lowering medications.
Kakavand H, Aghakouchakzadeh M, Shahi A, Virani SS, Dixon DL, Van Tassell BW, Talasaz AH. Kakavand H, et al. Among authors: aghakouchakzadeh m. J Clin Lipidol. 2022 Nov-Dec;16(6):822-832. doi: 10.1016/j.jacl.2022.10.003. Epub 2022 Oct 19. J Clin Lipidol. 2022. PMID: 36522804 Review.
Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI).
Hosseini SH, Talasaz AH, Alidoosti M, Tajdini M, Van Tassell BW, Etesamifard N, Kakavand H, Jalali A, Aghakouchakzadeh M, Gheymati A, Sadeghian M, Jenab Y. Hosseini SH, et al. Among authors: aghakouchakzadeh m. J Cardiovasc Pharmacol. 2022 Oct 1;80(4):592-599. doi: 10.1097/FJC.0000000000001317. J Cardiovasc Pharmacol. 2022. PMID: 35881907 Clinical Trial.
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GYH, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B. Talasaz AH, et al. Among authors: aghakouchakzadeh m. J Am Coll Cardiol. 2021 Oct 19;78(16):1635-1654. doi: 10.1016/j.jacc.2021.08.021. J Am Coll Cardiol. 2021. PMID: 34649702 Free PMC article. Review.
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Kakavand H, Ariannejad H, Connors JM, Hunt BJ, Berger JS, Van Tassell BW, Middeldorp S, Piazza G, Weitz JI, Cushman M, Lip GYH, Goldhaber SZ, Bikdeli B. Talasaz AH, et al. Among authors: aghakouchakzadeh m. J Thromb Haemost. 2021 Dec;19(12):3080-3089. doi: 10.1111/jth.15533. Epub 2021 Sep 30. J Thromb Haemost. 2021. PMID: 34538017 Free PMC article.
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GY, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B. Talasaz AH, et al. Among authors: aghakouchakzadeh m. medRxiv [Preprint]. 2021 May 4:2021.05.03.21256468. doi: 10.1101/2021.05.03.21256468. medRxiv. 2021. PMID: 33972948 Free PMC article. Updated. Preprint.
13 results